2022
DOI: 10.1080/15321819.2022.2071127
|View full text |Cite
|
Sign up to set email alerts
|

Evidence of hepatitis B infection and co-infection with enteric fever among febrile patients in a primary health facility in Kogi State, Nigeria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 13 publications
1
1
0
Order By: Relevance
“…Therefore, the current study provides the first serological evidence of HBV, HCV, and HIV infections among the apparently healthy population in the Idah metropolis. In the current study, HBsAg seropositivity rate of 2.8% was estimated, similar to low prevalence rates of 2.5% and 2.4% previously observed among asymptomatic populations in India (Neerja et al, 2012) and elsewhere in the state (Arome and Oseni, 2021) but lower than the HBV national prevalence of 11% in 2018 (Abutu, 2018), 9.5% prevalence from a meta-analytic study of pooled published data from 2010 and 2019 (Ajuwon et al, 2021) and 6-10% prevalence rates previously observed among febrile population and apparently healthy students of a tertiary institution elsewhere in the state (Okolo et al, 2022;Omatola et al, 2018). Similar to HBV, a comparatively low prevalence of HCV (0.2%) and HIV (0.3%) was observed in our study.…”
Section: Resultssupporting
confidence: 84%
See 1 more Smart Citation
“…Therefore, the current study provides the first serological evidence of HBV, HCV, and HIV infections among the apparently healthy population in the Idah metropolis. In the current study, HBsAg seropositivity rate of 2.8% was estimated, similar to low prevalence rates of 2.5% and 2.4% previously observed among asymptomatic populations in India (Neerja et al, 2012) and elsewhere in the state (Arome and Oseni, 2021) but lower than the HBV national prevalence of 11% in 2018 (Abutu, 2018), 9.5% prevalence from a meta-analytic study of pooled published data from 2010 and 2019 (Ajuwon et al, 2021) and 6-10% prevalence rates previously observed among febrile population and apparently healthy students of a tertiary institution elsewhere in the state (Okolo et al, 2022;Omatola et al, 2018). Similar to HBV, a comparatively low prevalence of HCV (0.2%) and HIV (0.3%) was observed in our study.…”
Section: Resultssupporting
confidence: 84%
“…In Kogi State, HIV, HBV, or HCV infection has been widely documented in different populations (Omatola et al, 2018;Okolo et al, 2022). Though, little or no information exists with regards to HIV, HBV, or HCV in Idah albeit in asymptomatic individuals in the area.…”
Section: Introductionmentioning
confidence: 99%